Teleflex Incorporated (TFX) to Issue Quarterly Dividend of $0.34 on March 17th

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Thursday, February 27th, RTT News reports. Stockholders of record on Friday, March 7th will be paid a dividend of 0.34 per share by the medical technology company on Monday, March 17th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Friday, March 7th.

Teleflex has a payout ratio of 8.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Stock Performance

Shares of TFX opened at $136.46 on Wednesday. The company has a market capitalization of $6.34 billion, a PE ratio of 26.02, a PEG ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company’s 50 day moving average price is $173.65 and its 200 day moving average price is $203.17. Teleflex has a 52 week low of $128.55 and a 52 week high of $249.90.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts expect that Teleflex will post 13.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

TFX has been the topic of a number of recent analyst reports. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Wells Fargo & Company dropped their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Morgan Stanley cut their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday. Piper Sandler reissued a “neutral” rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Bank of America lowered Teleflex from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $235.00 to $140.00 in a research report on Tuesday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Teleflex presently has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.